8.6.2017 16:25 | Business Wire
Industry Leaders Gather at IBC Leaders’ Summit to Discuss Transformation, Growth and Reinvention
IBC announces today the IBC2017 Leaders’ Summit, an exclusive invitation-only event in partnership with the City of Amsterdam and IBM Global Business Services for broadcast, telco, media and entertainment industry leaders.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170608005802/en/
This year’s event focuses on how businesses are transforming for the future, where speed and agility are two key components to any forward-thinking strategy.
A prestigious line-up of speakers has been assembled to explore the theme of “Informing the Future” at this year’s Summit, including Carsten Schmidt, CEO, Sky Deutschland who will discuss the current and future face of the company’s business and give an exclusive insight into Sky Deutschland’s co-produced drama Babylon Berlin , the most expensive non-English-language drama series ever made.
Wim Ponnet, Group Director Strategy and Commercial Development, EndemolShineGroup and Aksel Van der Wal, EVP Digital Ventures & Innovation, International, for Turner will also join the line-up to discuss “How to Engage with Gen Z Audiences”.
Sponsored by Aspera, HGST, Prime Focus and Sony, the IBC Leaders' Summit blends penetrating insights from influential speakers and facilitated networking along with independent and exclusive research provided by IBC’s research partner IBM GBS.
IBM GBS is reprising its role as IBC’s research partner and will present valuable new findings at the IBC Leaders' Summit.
Daniel Toole, Executive Partner, Media and Entertainment Industry Leader, IBM GBS, said, “IBM provides the IBC Leaders’ Summit with consumer insight, strategic business analysis and technology trends. We also bring unique research and qualitative analysis through the knowledge and personal experience gleaned from CEOs across the world, which will inform and inspire future technological and strategic developments.”
Designed specifically to bring together the most influential and visionary people at the top of the industry, the IBC Leaders' Summit provides a programme that facilitates high-powered discussion and lively debate. It takes place behind closed doors, allowing delegates to speak their minds, address the issues and highlight their concerns in an open and inspiring environment.
This two-day event is held in Amsterdam on 14-15 September 2017.
## ENDS ##
IBC is the world’s leading media, entertainment and technology show. It attracts 55,000+ attendees from more than 170 countries and combines a highly respected and peer-reviewed conference with an exhibition that showcases more than 1,700 leading suppliers of state of the art electronic media and entertainment technology.
|Conference:||14 – 18 September 2017|
|Exhibition:||15 – 19 September 2017|
For more information about IBC2017 visit: https://show.ibc.org/
Louise Wells, Bubble Communications
T: +44 7718 985 252
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
NY-IFF/ZOOMESSENCE23.6.2017 14:48 | pressemeddelelse
IFF and ZoomEssence Announce Settlement of Lawsuit
BIOGEN23.6.2017 13:57 | pressemeddelelse
Biogen’s IMRALDI®, an Adalimumab Biosimilar Candidate Referencing Humira®, Granted Positive Opinion by Committee for Medicinal Products for Human Use
EUSA-PHARMA23.6.2017 13:38 | pressemeddelelse
EUSA Pharma Receive Positive Opinion from The CHMP For tivozanib For The First-Line Treatment of Advanced Renal Cell Carcinoma In The European Union
CA-GILEAD-SCIENCES,-INC.23.6.2017 13:37 | pressemeddelelse
European CHMP Adopts Positive Opinion for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Chronic Hepatitis C Genotypes
SAMSUNG-BIOEPIS23.6.2017 13:32 | pressemeddelelse
Samsung Bioepis' Imraldi® (Adalimumab) Recommended for Approval by European Medicines Agency
MA-BLUEBIRD-BIO23.6.2017 13:02 | pressemeddelelse
bluebird bio Presents New Data from HGB-205 Study of LentiGlobinTM Drug Product in Patients with Transfusion-Dependent β-Thalassemia (TDT) and Severe Sickle Cell Disease (SCD) at European Hematology Association (EHA) Annual Meeting
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum